Contrapill Kit

国家: 印度

语言: 英文

来源: Central Drugs Standard Control Organization

现在购买

产品特点 产品特点 (SPC)
27-04-2024

有效成分:

Mifepristone, Misoprostol

可用日期:

Cadila Pharma

剂量:

mifopristone 200mg, misoprostol 200 μg

药物剂型:

Tablet

组成:

1 tablet of mifepristone 200, 4 tablets of misoprostol 200 mcg

给药途径:

Oral

每包单位数:

1 KIT (1+4)

治疗组:

Hormones, Contraceptives and Related Drugs

疗效迹象:

Medical termination of pregnancy of up to 49 days, cervical dilatation prior to surgical termination of pregnancy in the first trimester, therapeutic termination of pregnancy for medical reasons beyond the first trimester, labor induction in case of fetal death in utero.

产品特点

                                MIFEPRISTONE + MISOPROSTOL
Pregnancy Category-X
Schedule H
INDICATIONS 
Medical termination of pregnancy of up to 49 days,
cervical dilatation prior to surgical termination of 
pregnancy in the first trimester, therapeutic termination of
pregnancy for medical reasons beyond the 
first trimester, labor induction in case of fetal death
in utero.
AVAILABILITY 
Tablet KIT mifopristone 200mg, misoprostol 200 μg.
DOSE 
Mifepristone 200 mg orally followed 1 to 3 days latter by
misoprostol 800 μg vaginally.
Patients should return for follow up visit after approximately 14
days after administration of 
mifepristone.
CONTRAINDICATIONS
Hypersensitivity to Mifepristone, Misoprostol or
other prostaglandin; confirmed or suspected ectopic 
pregnancy; chronic adrenal failure; haemorrhagic disorders or
concurrent anticoagulant therapy; 
inherited porphyria.
PRECAUTIONS
IUD in
place; asthma, chronic obstructive pulmonary disease; alcoholism; prosthetic heart valve; 
infective endocarditis;, pregnancy.
ADVERSE EFFECTS
Abdominal pain, diarrhoea, nausea, vomiting; fever, chills,
uterine cramping; vaginal bleeding or 
spotting; Pelvic inflammatory disease.
INTERACTIONS
Dexamethasone: decreased serum levels of mifepristone
-------------------------
DOCUMENT OUTLINE	* Mifepristone + Misoprostol [/In_18294_SPC.html#1]	* Indications [/In_18294_SPC.html#1]	* Availability [/In_18294_SPC.html#1]	* Dose [/In_18294_SPC.html#1]	* Contraindications [/In_18294_SPC.html#1]	* Precautions [/In_18294_SPC.html#1]	* Adverse Effects [/In_18294_SPC.html#1]	* Interactions [/In_18294_SPC.html#1]
                                
                                阅读完整的文件